Ratha Mahendran

Mahendran Ratha

  • Senior Research Fellow, Department of Surgery
Administrative Appointment(s)
  • Member, Institutional Biosafety Committee, National University of Singapore
  • Member, MD4 & MD11 Central Research Facilities Safety Committee, NUS Yong Loo Lin School of Medicine
Academic Qualifications
  • PhD, University of Texas at Dallas, USA
  • BSc (Honours), National University of Singapore, Singapore
Research Interest(s)
  • Bladder Cancer
  • Immunotherapy
  • SNPs
  • BCG
  • Animal Models
Recent Publications
  • 1. Lim, H. W., Saw, W. Y., Feng, L., Lee, Y. K., Mahendran, R., Cheah, I. K. M., . . . Tan, E. C. (2018). Dataset on gene expression in the elderly after Mindfulness Awareness Practice or Health Education Program. Data in Brief, 18, 902-912. doi:10.1016/j.dib.2018.03.086
  • 2. Rahmat, J. N., Esuvaranathan, K., & Mahendran, R. (2018). Bacillus Calmette-GuĂ©rin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival. Oncology Letters, 15(6), 9231-9241. doi:10.3892/ol.2018.8462
  • 3. Yip, L. Y., Aw, C. C., Lee, S. H., Hong, Y. S., Ku, H. C., Xu, W. H., . . . Chan, E. C. Y. (2018). The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat. HEPATOLOGY, 67(1), 282-295. doi:10.1002/hep.29327
  • 4. Tham, S. M., Esuvaranathan, K., & Mahendran, R. (2017). A Murine Orthotopic Bladder Tumor Model and Tumor Detection System. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, (119), 12 pages. doi:10.3791/55078
  • 5. Mahendran, R. (2017). Bacillus Calmette-Guerin immunotherapy-increasing dose as a means of improving therapy?. TRANSLATIONAL CANCER RESEARCH, 6, S168-S173. doi:10.21037/tcr.2017.01.25